Donald Trump’s ‘ROCKSTAR’ FDA Pick Is Out Amid GOP Disagreement
(Photo Credit: Kevin Dietsch/Staff via Getty Images)

Donald Trump’s ‘ROCKSTAR’ FDA Pick Is Out Amid GOP Disagreement

Dr. Heidi Overton will reportedly not lead the Food and Drug Administration. The White House pulled her nomination after Republican senators raised objections to her positions on abortion, vaccines, and vaping. President Donald Trump had championed Overton as a “ROCKSTAR in my Administration” when he selected her in August, but the pick collapsed before the Senate HELP Committee could vote this week.

Why the White House dropped its nominee before a Senate committee vote

Multiple GOP senators reportedly opposed Heidi Overton’s stances on abortion, vaccines, and vaping, leaving her confirmation fight uphill from the start (via ABC News). Sen. Bill Cassidy, R-La., who chairs the Senate Health, Education, Labor, and Pensions (HELP) Committee, disputed the White House’s rationale.

Cassidy said on X he believed Overton would have won both the committee vote and a full Senate vote. “The [White House] said that this was because she did not have the votes to pass,” Cassidy said. “This was odd as I was having productive conversations with members. I believe she would have had the votes to pass out of committee and pass the full Senate.”

Cassidy pinpointed the real obstacle: “The last issue was that pro-life Senators sought final assurances from the Administration regarding the Administration’s commitment to life issues. The Administration withdrew Dr. Overton rather than make such commitments.” He argued that with little time left in this Congressional session, Senate Democrats now control whether a new FDA commissioner gets confirmed.

Overton, a Trump loyalist and White House deputy director of Domestic Policy, faced bipartisan pushback at her September nomination hearing. Republican Sens. Susan Collins of Maine and Ashley Moody of Florida joined Democratic Sen. Patty Murray of Washington in challenging her vaping and anti-abortion positions.

All in all, the FDA has lacked a permanent leader for nearly seven months. Marty Makary resigned in April after clashing with the White House over authorization of fruit-flavored vapes. Acting FDA Commissioner Kyle Diamantas runs the agency in the meantime. President Donald Trump has not indicated when he will name a replacement for the FDA commissioner post. Whether the Senate will confirm a new nominee during a lame duck session remains uncertain.

TRENDING

X